Literature DB >> 16479175

Lessons learned fighting HIV can be applied to anti-cancer drug design.

Alla Gustchina1, Mariusz Jaskólski, Alexander Wlodawer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16479175     DOI： 10.4161/cc.5.5.2490

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  4 in total

1.  Atomistic simulations of the HIV-1 protease folding inhibition.

Authors:  Gennady Verkhivker; Guido Tiana; Carlo Camilloni; Davide Provasi; Ricardo A Broglia
Journal:  Biophys J       Date:  2008-03-28       Impact factor: 4.033

2.  Crystal structures of inhibitor complexes of human T-cell leukemia virus (HTLV-1) protease.

Authors:  Tadashi Satoh; Mi Li; Jeffrey-Tri Nguyen; Yoshiaki Kiso; Alla Gustchina; Alexander Wlodawer
Journal:  J Mol Biol       Date:  2010-06-30       Impact factor: 5.469

3.  C-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity.

Authors:  János Kádas; Péter Boross; Irene T Weber; Péter Bagossi; Krisztina Matúz; József Tözsér
Journal:  Biochem J       Date:  2008-12-15       Impact factor: 3.857

4.  Crystal structure of XMRV protease differs from the structures of other retropepsins.

Authors:  Mi Li; Frank Dimaio; Dongwen Zhou; Alla Gustchina; Jacek Lubkowski; Zbigniew Dauter; David Baker; Alexander Wlodawer
Journal:  Nat Struct Mol Biol       Date:  2011-01-23       Impact factor: 15.369
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.